Axiora Medical
Axiora Medical
Explore our precision titanium locking plates and advanced clinical equipment engineered for optimal patient outcomes.
In modern orthopedic reconstructive and trauma surgery, the clinical transition from conventional dynamic compression plates (DCP) to locked internal fixators marks one of the most vital paradigms shifts in osteosynthesis. Titanium locking plates operate as high-performance internal fixators, retaining stability through a threaded locking interface between the screw head and the plate. By utilizing this rigid mechanical structure, these systems effectively prevent the plate from compressing the underlying periosteum, thereby conserving regional blood supply and facilitating faster, biology-driven fracture healing.
As a leading titanium locking plates manufacturer in China, Axiora Medical Technology (China) Co., Ltd. is at the forefront of this technological shift. By merging precision metallurgical standards, advanced CAD/CAM modeling, and ISO-certified quality control, we supply distributors, OEM brands, and hospitals worldwide with implants that guarantee mechanical reliability under extreme physiologic loads. Utilizing medical-grade titanium alloys (Ti-6Al-4V ELI / ASTM F136), our locking systems strike the ideal balance between low modulus of elasticity, high fatigue resistance, and unmatched biocompatibility.
Axiora Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.
Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.
With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements. From product design and prototyping to mass production and packaging, our integrated manufacturing process ensures consistent quality, competitive pricing, and on-time delivery. Today, Axiora exports its orthopedic products to customers across Europe, North America, South America, the Middle East, Southeast Asia, and Africa, building long-term partnerships with medical device distributors, brand owners, hospitals, and healthcare organizations around the world.
| Corporate Parameter | Technical Specification / Operational Scope |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand Label | Axiora |
| Official Website | www.axioraortho.com |
| Year Established | 2017 |
| Export Footprint | 8 Years of Global Trade and Logistics Compliance |
| QC Framework | 100% Finished Product Inspection & Rigorous Incoming Material Testing |
| Testing Methodologies | Coordinate Measuring Machine (CMM), Tensile Strength Testing, Rockwell/Vickers Hardness Testing, Surface Roughness Inspection, Salt Spray Corrosion Resistance Testing |
| Dedicated QC Staff | 48 Certified Quality Control Auditors |
| Business Paradigm | Contract Manufacturer (OEM & ODM) & Global Exporter |
| Core Global Markets | Europe, North America, Middle East, Southeast Asia, South America |
| Supply Chain Network | 1,120 Verified Partners for Raw Materials and Post-Processing |
| R&D Capabilities | Independent Design, Reverse Engineering, Finite Element Analysis (FEA), Rapid Prototyping |
| Customization Options | Laser Marking, Color Anodization, Custom Sterilized Packaging, Structural Modification |
| Product Velocity | 126 New Product Catalogs Released Last Year |
Visual representation of our lean production workflow from raw titanium raw stock to final sterile packaging, conforming to surgical-grade manufacturing standards.
As trauma orthopedics progresses, clinical demands require implants that not only offer stable fixation but also accelerate biological repair. The research and development division at Axiora coordinates with clinical research institutions to explore advanced technologies in osteosynthesis. Our technical roadmap focuses on the following primary developments:
Developing customizable angle-locking configurations (±15° cone variation) to accommodate complex periarticular fractures. This permits surgeons to tailor screw angles intraoperatively around critical joint structures without compromising locking integrity.
Integrating advanced electro-chemical treatment protocols to significantly raise titanium surface fatigue resistance while preventing soft tissue adhesion. This technique also acts as a barrier to reduce the release of metal ions into surrounding tissues.
Prototyping magnesium alloy and antimicrobial silver-ion nanocoatings on locking plate surfaces to lower the rate of implant-associated infections (IAI) and promote local bone remodeling through osteoinductive ion release.
The global orthopaedic supply chain demands resilience, regulatory compliance, and economic feasibility. Hospitals and medical brands often face inventory volatility and extended lead times when working with single-region operations. Axiora bridges this gap by acting as a robust manufacturing partner in China, operating with diversified shipping networks and stable domestic raw material supply links.
With 86 R&D engineers on site, Axiora translates 2D designs and 3D step files into finished surgical units. We offer comprehensive private labeling, customized surgical kit production, and customized anodized color-coding systems for quick identification in the OR. This reduces entry barriers for brand owners and distributors looking to expand their catalogs.
Our raw titanium is sourced exclusively from qualified metallurgical smelters. Each batch is accompanied by material test certificates (MTC) documenting physical properties and chemical composition in compliance with ASTM F136 and ISO 5832-3 standards. By maintaining safety stocks of critical plate geometries and screws, we reduce typical export delivery cycles to under 30 days.
To operate securely in European, Latin American, and North American markets, orthopedic hardware must meet stringent safety regulations. Axiora has built a quality management system certified under ISO 13485:2016. Every manufacturing phase, from raw ingot slicing to cleanroom packaging, is tracked using ERP systems to ensure trace-back verification for every component.
Our OQC labs feature state-of-the-art Coordinate Measuring Machines (CMM) to verify dimensional tolerancing down to ±3μm. Crucial for screw-thread mesh accuracy, this level of precision prevents locking failures and cold-welding complications during implant extraction.
Our in-house fatigue testing rigs replicate physiological cyclic load cycles (up to 5 million cycles) in accordance with ASTM F382 standards. This ensures that distal radius, clavicular, and humeral locking plates withstand postoperative stress patterns without mechanical failure.
We pack finished plates within Class 10,000 aseptic cleanrooms using medical-grade Tyvek film. This packaging maintains barrier integrity, ensuring safe delivery of sterile implants to surgical centers worldwide.
Key mechanical, chemical, and regulatory questions answered by our chief R&D engineering team.
Select from our surgical power tools, bio-absorbable materials, joint prostheses, and custom anatomical reconstruction systems.
